Literature DB >> 19190174

Mitogen-activated protein kinase pathways contribute to hypercontractility and increased Ca2+ sensitization in murine experimental colitis.

Eikichi Ihara1, Paul L Beck, Mona Chappellaz, Josee Wong, Shaun A Medlicott, Justin A MacDonald.   

Abstract

Inflammatory bowel disease (IBD) is associated with intestinal smooth muscle dysfunction. Many smooth muscle contractile events are associated with alterations in Ca(2+)-sensitizing pathways. The aim of the present study was to assess the effect of colitis on Ca(2+) sensitization and the signaling pathways responsible for contractile dysfunction in murine experimental colitis. Colitis was induced in BALB/c mice by providing 5% dextran sulfate sodium (DSS) in drinking water for 7 days. Contractile responses of colonic circular smooth muscle strips to 118 mM K(+) and carbachol (CCh) were assessed. DSS induced a T(H)2 colitis [increased interleukin (IL)-4 and IL-6] with no changes in T(H)1 cytokines. Animals exposed to DSS had increased CCh-induced contraction (3.5-fold) and CCh-induced Ca(2+)-sensitization (2.2-fold) responses in intact and alpha-toxin permeabilized colonic smooth muscle, respectively. The contributions of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) to CCh-induced contractions were significantly increased during colitis. Ca(2+)-independent contraction induced by microcystin was potentiated (1.5-fold) in mice with colitis. ERK and p38MAPK (but not Rho-associated kinase) contributed to this potentiation. ERK1/2 and p38MAPK expression were increased in the muscularis propria of colonic tissue from both DSS-treated mice and patients with IBD (ulcerative colitis >> Crohn's disease). Murine T(H)2 colitis resulted in colonic smooth muscle hypercontractility with increased Ca(2+) sensitization. Both ERK and p38MAPK pathways contributed to this contractile dysfunction, and expression of these molecules was altered in patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190174     DOI: 10.1124/mol.108.049858

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.

Authors:  Hirotada Akiho; Eikichi Ihara; Yasuaki Motomura; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2011-10-15

2.  Contribution of Rho-kinase to membrane excitability of murine colonic smooth muscle.

Authors:  O Bayguinov; L Dwyer; H Kim; A Marklew; K M Sanders; S D Koh
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.

Authors:  Lori D Moffat; Shannon B A Brown; Michael E Grassie; Annegret Ulke-Lemée; Laura M Williamson; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Regulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles.

Authors:  B P Bhetwal; C L An; S A Fisher; B A Perrino
Journal:  Neurogastroenterol Motil       Date:  2011-08-24       Impact factor: 3.598

5.  Decrease of guanylyl cyclase β1 subunit and nitric oxide (NO)-induced relaxation in mouse rectum with colitis and its reproduction on long-term NO treatment.

Authors:  Yuri Hamada; Erina Kato; Hiroyuki Nakamura; Hiromichi Fujino; Kenjiro Matsumoto; Kimihito Tashima; Shunji Horie; Toshihiko Murayama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

6.  Cellular mechanism of mechanotranscription in colonic smooth muscle cells.

Authors:  Feng Li; You-Min Lin; Sushil K Sarna; Xuan-Zheng Shi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-14       Impact factor: 4.052

7.  Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.

Authors:  Hirotada Akiho; Eikichi Ihara; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2010-08-15

8.  MAPKs represent novel therapeutic targets for gastrointestinal motility disorders.

Authors:  Eikichi Ihara; Hirotada Akiho; Kazuhiko Nakamura; Sara R Turner; Justin A Macdonald
Journal:  World J Gastrointest Pathophysiol       Date:  2011-04-15

9.  Therapeutic efficacy and mechanism of Zhenrenyangzang decoction in rats with experimental ulcerative colitis.

Authors:  Hui Wang; Shu-Hua Li; Yan Zhang; Jie Guan; Yan-Min Wu; Qi Wang; Xiao-Qing Luo
Journal:  Int J Clin Exp Med       Date:  2015-09-15

10.  Jun kinase-induced overexpression of leukemia-associated Rho GEF (LARG) mediates sustained hypercontraction of longitudinal smooth muscle in inflammation.

Authors:  Othman Al-Shboul; Ancy D Nalli; Divya P Kumar; Ruizhe Zhou; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.